The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
09 04 2019
Historique:
pubmed: 27 3 2019
medline: 23 5 2019
entrez: 27 3 2019
Statut: ppublish

Résumé

Mucin domains are densely

Identifiants

pubmed: 30910957
pii: 1813020116
doi: 10.1073/pnas.1813020116
pmc: PMC6462054
doi:

Substances chimiques

Antigens, CD 0
Antigens, Differentiation, Myelomonocytic 0
Escherichia coli Proteins 0
Lectins 0
Mucins 0
Neoplasm Proteins 0
SIGLEC7 protein, human 0
SIGLEC9 protein, human 0
Sialic Acid Binding Immunoglobulin-like Lectins 0
Metalloendopeptidases EC 3.4.24.-
StcE protein, E coli EC 3.4.24.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

7278-7287

Subventions

Organisme : NCI NIH HHS
ID : R01 CA227942
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM059907
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM120007
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA221244
Pays : United States

Déclaration de conflit d'intérêts

Conflict of interest statement: A patent application relating to the use of enzymes to digest mucin-domain glycoproteins has been filed by Stanford University (docket no. STAN-1510PRV). C.R.B. is a cofounder and Scientific Advisory Board member of Palleon Pharmaceuticals, Enable Bioscience, Redwood Biosciences (a subsidiary of Catalent), and InterVenn Biosciences, and a member of the Board of Directors of Eli Lilly & Company. O.D. has participated in advisory boards for Tesaro, Merck, and Geneos. O.D. is a speaker for Tesaro and AstraZeneca.

Références

Mol Microbiol. 2002 Jul;45(2):277-88
pubmed: 12123444
Elife. 2017 Dec 21;6:
pubmed: 29266001
Cell Microbiol. 2017 Jun;19(6):
pubmed: 28054754
Sci Rep. 2015 Jun 05;5:9759
pubmed: 26044153
PLoS One. 2012;7(1):e30287
pubmed: 22299034
Nat Methods. 2009 Mar;6(3):207-9
pubmed: 19234450
Infect Immun. 2005 Mar;73(3):1295-303
pubmed: 15731026
PLoS One. 2016 Nov 3;11(11):e0166119
pubmed: 27812179
Nat Rev Immunol. 2014 Oct;14(10):653-66
pubmed: 25234143
Angew Chem Int Ed Engl. 2018 Jul 20;57(30):9320-9324
pubmed: 29742324
Glycobiology. 2018 Aug 1;28(8):601-611
pubmed: 29796594
Nat Rev Cancer. 2009 Dec;9(12):874-85
pubmed: 19935676
Expert Rev Mol Diagn. 2010 Nov;10(8):1069-83
pubmed: 21080822
Mol Syst Biol. 2018 Nov 20;14(11):e8486
pubmed: 30459171
Protein Sci. 2014 Feb;23(2):123-44
pubmed: 24596965
Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):12574-9
pubmed: 26420872
Nat Immunol. 2002 Aug;3(8):764-71
pubmed: 12134145
Annu Rev Physiol. 1995;57:607-34
pubmed: 7778880
J Immunol. 2010 Mar 15;184(6):2743-9
pubmed: 20200285
Biochim Biophys Acta. 1995 Dec 20;1241(3):407-23
pubmed: 8547303
Cancer Prev Res (Phila). 2013 Jan;6(1):18-26
pubmed: 23248097
Crit Rev Biotechnol. 2018 Sep;38(6):851-867
pubmed: 29262720
Cell. 2016 Jan 14;164(1-2):128-140
pubmed: 26771488
Mol Cancer. 2010 May 24;9:118
pubmed: 20497550
Mol Biol Cell. 2000 Mar;11(3):819-31
pubmed: 10712502
Anal Biochem. 2009 Dec 15;395(2):178-88
pubmed: 19699707
Blood. 2005 Aug 1;106(3):779-86
pubmed: 15811952
Biochimie. 2010 Jan;92(1):1-11
pubmed: 19818375
Cell. 1986 Mar 14;44(5):749-59
pubmed: 3948246
Nat Methods. 2015 Jun;12(6):561-7
pubmed: 25894945
Cancer Res. 2007 Jul 1;67(13):6183-91
pubmed: 17616675
Chemistry. 2016 Jan 18;22(3):1114-24
pubmed: 26663535
Bioorg Med Chem. 2005 Sep 1;13(17):5021-34
pubmed: 16005634
J Innate Immun. 2017;9(3):281-299
pubmed: 28052300
J Proteomics. 2014 Aug 28;108:258-68
pubmed: 24907489
Gut Microbes. 2014 Jan-Feb;5(1):48-52
pubmed: 24149677
Nat Rev Cancer. 2004 Jan;4(1):45-60
pubmed: 14681689
Chem Soc Rev. 2017 Nov 27;46(23):7154-7175
pubmed: 29022615
Cell. 2015 Apr 9;161(2):205-14
pubmed: 25860605
ACS Biomater Sci Eng. 2018 Feb 12;4(2):388-399
pubmed: 29805991
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):E679-E688
pubmed: 28096352
Ann N Y Acad Sci. 2012 Apr;1253:16-36
pubmed: 22524423
J Biol Chem. 1983 May 25;258(10):6335-9
pubmed: 6406478
Immunity. 2016 Jun 21;44(6):1444-54
pubmed: 27332733
Annu Rev Biochem. 2004;73:491-537
pubmed: 15189151
Immunology. 2016 Nov;149(3):280-296
pubmed: 27392084
Nat Phys. 2018;14(7):658-669
pubmed: 33859716
J Bacteriol. 2006 Jul;188(13):4646-53
pubmed: 16788173
Cancer Res. 2007 May 15;67(10):4924-32
pubmed: 17510422
Methods Mol Biol. 2012;842:67-79
pubmed: 22259130
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10304-9
pubmed: 27551071
Mol Pharmacol. 2011 May;79(5):886-93
pubmed: 21346142
Immunol Rev. 2017 Mar;276(1):178-191
pubmed: 28258691
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8877-82
pubmed: 24889612
J Mol Biol. 1993 Jul 20;232(2):620-38
pubmed: 8345526
Chemistry. 2017 Mar 8;23(14):3466-3473
pubmed: 28079948
J Biol Chem. 2010 Feb 19;285(8):5759-75
pubmed: 19951948
Structure. 2012 Apr 4;20(4):707-17
pubmed: 22483117
PLoS Pathog. 2017 Aug 21;13(8):e1006558
pubmed: 28827841
Mol Cancer. 2014 May 29;13:129
pubmed: 24886523
Eur J Immunol. 2003 Jun;33(6):1642-8
pubmed: 12778482
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2105-10
pubmed: 23345451
J Immunol. 2008 Jun 1;180(11):7385-93
pubmed: 18490738
Glycobiology. 2005 Feb;15(2):153-64
pubmed: 15385431
Mol Cell Proteomics. 2013 Apr;12(4):932-44
pubmed: 23399548
Nat Commun. 2016 Feb 17;7:10501
pubmed: 26883990
Cell. 1995 Oct 20;83(2):333-43
pubmed: 7585950
Anal Chem. 2018 Jul 3;90(13):8261-8269
pubmed: 29936827
Glycobiology. 2017 Jul 1;27(7):657-668
pubmed: 28369504
Cell. 2000 Oct 27;103(3):467-79
pubmed: 11081633
Chembiochem. 2014 May 5;15(7):939-45
pubmed: 24753400
Glycobiology. 2012 Jul;22(7):918-29
pubmed: 22422444
J Am Chem Soc. 2002 Aug 21;124(33):9833-44
pubmed: 12175243
Cell Immunol. 2018 Nov;333:34-45
pubmed: 29602445
Exp Cell Res. 2008 Jun 10;314(10):2004-15
pubmed: 18456258

Auteurs

Stacy A Malaker (SA)

Department of Chemistry, Stanford University, Stanford, CA 94305.

Kayvon Pedram (K)

Department of Chemistry, Stanford University, Stanford, CA 94305.

Michael J Ferracane (MJ)

Department of Chemistry, University of Redlands, Redlands, CA 92373.

Barbara A Bensing (BA)

Department of Medicine, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, CA 94143.

Venkatesh Krishnan (V)

Stanford Women's Cancer Center, Division of Gynecologic Oncology, Stanford University, Stanford, CA 94305.

Christian Pett (C)

Leibniz-Institut für Analytische Wissenschaften (ISAS), 44227 Dortmund, Germany.
Department of Chemistry, Umeå University, 901 87 Umeå, Sweden.

Jin Yu (J)

Leibniz-Institut für Analytische Wissenschaften (ISAS), 44227 Dortmund, Germany.

Elliot C Woods (EC)

Department of Chemistry, Stanford University, Stanford, CA 94305.

Jessica R Kramer (JR)

Department of Bioengineering, University of Utah, Salt Lake City, UT 84112.

Ulrika Westerlind (U)

Leibniz-Institut für Analytische Wissenschaften (ISAS), 44227 Dortmund, Germany.
Department of Chemistry, Umeå University, 901 87 Umeå, Sweden.

Oliver Dorigo (O)

Stanford Women's Cancer Center, Division of Gynecologic Oncology, Stanford University, Stanford, CA 94305.

Carolyn R Bertozzi (CR)

Department of Chemistry, Stanford University, Stanford, CA 94305; bertozzi@stanford.edu.
Howard Hughes Medical Institute, Stanford, CA 94305.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH